COVID – 19 | Vaccination Update – Day 615

0
38
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 217.24 Crore (2,17,24,02,780today. More than 11 lakh (11,72,455) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10414940
2nd Dose 10115613
Precaution Dose 6966956
FLWs 1st Dose 18436344
2nd Dose 17712553
Precaution Dose 13549531
Age Group 12-14 years 1st Dose 40895595
  2nd Dose 31442091
Age Group 15-18 years 1st Dose 61901810
  2nd Dose 52919115
Age Group 18-44 years 1st Dose 561145894
2nd Dose 515272566
Precaution Dose 88212285
Age Group 45-59 years 1st Dose 204006983
2nd Dose 196846497
Precaution Dose 45862322
Over 60 years 1st Dose 127652274
2nd Dose 123062599
Precaution Dose 45986812
Cumulative 1st dose administered 1024453840
Cumulative 2nd dose administered 947371034
Precaution Dose 200577906
Total 2172402780

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 22nd September, 2022 (615th Day)
HCWs 1st Dose 9
2nd Dose 113
Precaution Dose 5259
FLWs 1st Dose 34
2nd Dose 220
Precaution Dose 9373
Age Group 12-14 years 1st Dose 19487
  2nd Dose 61681
Age Group 15-18 years 1st Dose 6971
  2nd Dose 19854
Age Group 18-44 years 1st Dose 12778
2nd Dose 52589
Precaution Dose 603694
Age Group 45-59 years 1st Dose 1910
2nd Dose 10684
Precaution Dose 245483
Over 60 years 1st Dose 1238
2nd Dose 6329
Precaution Dose 114749
Cumulative 1st dose administered 42427
Cumulative 2nd dose administered 151470
Precaution Dose 978558
Total 1172455

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.